Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review.

ABSTRACT:

Background

Pregnant women with COVID-19 are at an increased risk of severe COVID-19 illness as well as adverse pregnancy and birth outcomes. Many countries are vaccinating or considering vaccinating pregnant women with limited available data about the safety of this strategy. Early identification of safety concerns of COVID-19 vaccines, including their components, or their technological platforms is therefore urgently needed.

Methods

We conducted a rapid systematic review, as the first phase of an ongoing full systematic review, to evaluate the safety of COVID-19 vaccines in pregnant women, including their components, and their technological platforms (whole virus, protein, viral vector or nucleic acid) used in other vaccines, following the Cochrane methods and the PRISMA st

SUBMITTER: Ciapponi A 

PROVIDER: S-EPMC8202435 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature